|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Center for Epidemiology: Cancer incidence
in Sweden 2011. National Board of Health and Welfare
(SocialStyrelsen) (Stockholm, Sweden). 2011.
|
|
3
|
Lind M, Lewin F, Lundgren J, Nathanson ALF
and Strander H: Head, neck and oesophageal cancer: Diagnosis,
treatment and follow-up of the Stockholm-Gotland region. Karolinska
University Hospital (Stockholm). Oncological Centrum. 2001.(In
Swedish) Available from. http://www.cancercentrum.se/Global/RCCSthlmGotland/Regionla%20vårdprogram/HuvudhalsEsofaguscancer2001%5B1%5D.pdfAccessed.
July 11–2014
|
|
4
|
Panwar A, Batra R, Lydiatt WM and Ganti
AK: Human papilloma virus positive oropharyngeal squamous cell
carcinoma: A growing epidemic. Cancer Treat Rev. 40:215–219. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hammarstedt L, Lindquist D, Dahlstrand H,
Romanitan M, Dahlgren LO, Joneberg J, Creson N, Lindholm J, Ye W,
Dalianis T and Munck-Wikland E: Human papillomavirus as a risk
factor for the increase in incidence of tonsillar cancer. Int J
Cancer. 119:2620–2623. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gillison ML, Zhang Q, Jordan R, Xiao W,
Westra WH, Trotti A, Spencer S, Harris J, Chung CH and Ang KK:
Tobacco smoking and increased risk of death and progression for
patients with p16-positive and p16-negative oropharyngeal cancer. J
Clin Oncol. 30:2102–2111. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blomberg M, Nielsen A, Munk C and Kjaer
SK: Trends in head and neck cancer incidence in Denmark, 1978-2007:
Focus on human papillomavirus associated sites. Int J Cancer.
129:733–741. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Olaleye O, Moorthy R, Lyne O, Black M,
Mitchell D and Wiseberg J: A 20-year retrospective study of tonsil
cancer incidence and survival trends in South East England:
1987-2006. Clin Otolaryngol. 36:325–335. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klussmann JP, Weissenborn SJ, Wieland U,
Dries V, Eckel HE, Pfister HJ and Fuchs PG: Human
papillomavirus-positive tonsillar carcinomas: A different tumor
entity? Med Microbiol Immunol. 192:129–132. 2003.(In Swedish).
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kreimer AR, Clifford GM, Boyle P and
Franceschi S: Human papillomavirus types in head and neck squamous
cell carcinomas worldwide: A systematic review. Cancer Epidemiol
Biomarkers Prev. 14:467–475. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Haughey BH, Hinni ML, Salassa JR, et al:
Transoral laser microsurgery as primary treatment for
advanced-stage oropharyngeal cancer: A United States multicenter
study. Head Neck. 33:1683–1694. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Richmon JD, Quon H and Gourin CG: The
effect of transoral robotic surgery on short-term outcomes and cost
of care after oropharyngeal cancer surgery. Laryngoscope.
124:165–171. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nichols AC, Faquin WC, Westra WH, Mroz EA,
Begum S, Clark JR and Rocco JW: HPV-16 infection predicts treatment
outcome in oropharyngeal squamous cell carcinoma. Otolaryngol Head
Neck Surg. 140:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
O'Rorke MA, Ellison MV, Murray LJ, Moran
M, James J and Anderson LA: Human papillomavirus related head and
neck cancer survival: A systematic review and meta-analysis. Oral
Oncol. 48:1191–1201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mellin H, Friesland S, Lewensohn R,
Dalianis T and Munck-Wikland E: Human papillomavirus (HPV) DNA in
tonsillar cancer: Clinical correlates, risk of relapse and
survival. Int J Cancer. 89:300–304. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schiffman M and Castle PE: Human
papillomavirus: Epidemiology and public health. Arch Pathol Lab
Med. 127:930–934. 2003.PubMed/NCBI
|
|
17
|
D'souza G and Dempsey A: The role of HPV
in head and neck cancer and review of the HPV vaccine. Prev Med.
55(Suppl 1): S5–S11. 2011. View Article : Google Scholar
|
|
18
|
Steinau M, Saraiya M, Goodman MT, Peters
ES, Watson M, Cleveland JL, Lynch CF, Wilkinson EJ, Hernandez BY
and Copeland G: Human papillomavirus prevalence in oropharyngeal
cancer before vaccine introduction, United States. Emerg Infect
Dis. 20:822–828. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Osazuwa-Peters N: Human papillomavirus
(HPV), HPV-associated oropharyngeal cancer and HPV vaccine in the
United States-do we need a broader vaccine policy? Vaccine.
31:5500–5505. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Williams JR: The Declaration of Helsinki
and public health. Bull World Health Organ. 86:650–652. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Roda Husman AM, Walboomers JM, van den
Brule AJ, Meijer CJ and Snijders PJ: The use of general primers GP5
and GP6 elongated at their 3′ ends with adjacent highly conserved
sequences improves human papillomavirus detection by PCR. J Gen
Virol. 76:1057–1062. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Smits HL, Tieben LM, Tjong-A-Hung SP,
Jebbink MF, Minnaar RP, Jansen CL and ter Schegget J: Detection and
typing of human papillomaviruses present in fixed and stained
archival cervical smears by a consensus polymerase chain reaction
and direct sequence analysis allow the identification of a broad
spectrum of human papillomavirus types. J Gen Virol. 73:3263–3268.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Detre S, Saclani Jotti G and Dowsett M: A
‘quickscore’ method for immunohistochemical semiquantitation:
Validation for oestrogen receptor in breast carcinomas. J Clin
Pathol. 48:876–878. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sweden Official Statistics: Urban areas
2010. Statistical Central Office (Stockholm, Sweden). 2012.(In
Swedish).
|
|
25
|
Sweden Official Statistics: Smaller
localities 2010. Statistical Central Office (Stockholm, Sweden).
2012.(In Swedish).
|
|
26
|
Nordlund LA: Trends in smoking habits and
lung cancer in Sweden. Eur J Cancer Prev. 7:109–116.
1998.PubMed/NCBI
|
|
27
|
Golas SM: Trends in palatine tonsillar
cancer incidence and mortality rates in the United States.
Community Dent Oral Epidemiol. 35:98–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hammarstedt L, Dahlstrand H, Lindquist D,
et al: The incidence of tonsillar cancer in Sweden is increasing.
Acta Otolaryngol. 127:988–992. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Näsman A, Attner P, Hammarstedt L, et al:
Incidence of human papillomavirus (HPV) positive tonsillar
carcinoma in Stockholm, Sweden: An epidemic of viral-induced
carcinoma? Int J Cancer. 125:362–366. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dahlstrand HM and Dalianis T: Presence and
influence of human papillomaviruses (HPV) in Tonsillar cancer. Adv
Cancer Res. 93:59–89. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Syrjänen S: HPV infections and tonsillar
carcinoma. J Clin Pathol. 57:449–455. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Oguejiofor KK, Hall JS, Mani N, et al: The
Prognostic Significance of the Biomarker p16 in Oropharyngeal
Squamous Cell Carcinoma. Clin Oncol (R Coll Radiol). 25:630–638.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mellin Dahlstrand H, Lindquist D,
Björnestål L, et al: P16(INK4a) correlates to human papillomavirus
presence, response to radiotherapy and clinical outcome in
tonsillar carcinoma. Anticancer Res. 25:4375–4383. 2005.PubMed/NCBI
|
|
34
|
Weinberger PM, Yu Z, Haffty BG, et al:
Molecular classification identifies a subset of human
papillomavirus-associated oropharyngeal cancers with favorable
prognosis. J Clin Oncol. 24:736–747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lindquist D, Romanitan M, Hammarstedt L,
Näsman A, Dahlstrand H, Lindholm J, Onelöv L, Ramqvist T, Ye W,
Munck-Wikland E and Dalianis T: Human papillomavirus is a
favourable prognostic factor in tonsillar cancer and its oncogenic
role is supported by the expression of E6 and E7. Mol Oncol.
1:350–355. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fischer CA, Kampmann M, Zlobec I, Green E,
Tornillo L, Lugli A, Wolfensberger M and Terracciano LM: p16
expression in oropharyngeal cancer: Its impact on staging and
prognosis compared with the conventional clinical staging
parameters. Ann Oncol. 21:1961–1966. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Goldenberg D, Begum S, Westra WH, Khan Z,
Sciubba J, Pai SI, Califano JA, Tufano RP and Koch WM: Cystic lymph
node metastasis in patients with head and neck cancer: An
HPV-associated phenomenon. Head Neck. 30:898–903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lassen P, Eriksen JG, Hamilton-Dutoit S,
Tramm T, Alsner J and Overgaard J: Effect of HPV-associated
p16INK4A expression on response to radiotherapy and survival in
squamous cell carcinoma of the head and neck. J Clin Oncol.
27:1992–1998. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Marklund L and Hammarstedt L: Impact of
HPV in Oropharyngeal Cancer. J Oncol. 2011:5090362011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hemminki K, Dong C and Frisch M: Tonsillar
and other upper aerodigestive tract cancers among cervical cancer
patients and their husbands. Eur J Cancer Prev. 9:433–437. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gillison ML, Broutian T, Pickard RK, Tong
ZY, Xiao W, Kahle L, Graubard BI and Chaturvedi AK: Prevalence of
oral HPV infection in the United States, 2009-2010. Jama.
307:693–703. 2012. View Article : Google Scholar : PubMed/NCBI
|
